Skip to content

Fluoroscopic Guided Interlaminar Epidural Versus Ultrasound Guided Transforaminal Epidural in the Treatment of Unilateral Cervicobrachialgia.

Fluoroscopic Guided Interlaminar Epidural Versus Ultrasound Guided Transforaminal Epidural in the Treatment of Unilateral Cervicobrachialgia : a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04475445
Enrollment
60
Registered
2020-07-17
Start date
2020-07-30
Completion date
2021-07-31
Last updated
2020-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervicobrachial Neuralgia

Keywords

Neuropathic Cervicobrachial, Ultrasound-guided transforaminal infiltration, Cervical Interlaminar epidural infiltration, Cervical Chronic Pain

Brief summary

Chronic cervicobrachialgia is a public health problem. Epidural injections of corticosteroids and local anesthesics via transforaminal and interlaminar routes both have shown their potential in its treatment. The interlaminar approach offers the advantage of an epidural injection (i.e., direct contact with the nerve root in the epidural space). However, it requires fluoroscopy and can lead to potentially serious complications (compression of the nerve root, spinal cord injury...). The ultrasound-guided injection of corticosteroids via the transforaminal route, which offers the advantage of selectively targeting the symptomatic nerve root, may have the same therapeutic advantages as the interlaminar approach in decreasing unilateral cervicobrachial pain (i.e. a decrease in pain after infiltration) and reduce its risks.The aim of this study is to compare the efficacy of transforaminal vs interlaminar cervical corticosteroid injection.

Interventions

OTHERUltrasound-guided transforaminal epidural steroid injection

Ultrasound identification of the nerve root, fluoroscopic control of the position and injection of a mixture of 10 mg of dexamethasone and 20 mg of lidocaine.

Fluoroscopic location of the epidural space C5C6 or C6C7, injection of a mixture of 10 mg of dexamethasone and 20 mg of lidocaine.

Sponsors

Centre Hospitalier Universitaire Saint Pierre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists physical status (ASA) I-III * Chronic unilateral cervicobrachial pain * Allowed Steroid infiltration

Exclusion criteria

* Pregnancy * Lactation * Allergy or intolerance to any of the drugs/materials used in this study, * Participation in another interventional study * Systemic anticoagulation, * Infection at the puncture site * Patient refusal.

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue Score change at 30 minutes post infiltration when compared to baselineup to 30 minutesPain will be evaluated by Visual Analog Scale (VAS) before and 30 minutes after corticosteroid infiltration. Visual Analog pain score (scale = 0 no pain; 10= worst pain imaginable)

Secondary

MeasureTime frameDescription
Visual Analogue Score change at 1 month post infiltration when compared to baselineup to 1 monthPain will be evaluated by Visual Analog Scale (VAS) before and 1 month after corticosteroid infiltration. Visual Analog pain score (scale = 0 no pain; 10= worst pain imaginable)
Patient satisfaction during procedureat the end of infiltrationPain will be evaluated by Satisfaction scale after procedure (0= unsatisfied, 5= very satisfied)
Incidence of Adverse effects (lipothymia, nausea, vomiting)up to 1 month
Rate of Procedure failureup to 30 minutesThe procedure will be considered as a failure if the infiltration is not performed.
Incidence of complications (stroke, hematoma, paralysis)up to 1 month
Neck disability index (NDI) score (questionnaire)up to 1 monthNeck disability index (NDI) score will be calculated before, 30 minutes and 1 month after corticosteroid infiltration The NDI is a standard instrument for measuring self-rated disability due to neck pain. Each of the 10 items is scored from 0 - 5. The maximum score is therefore 50. Points summed to a total score. The test can be interpreted as a raw score, with a maximum score of 50, Interpretation for scoring intervals : 0 - 4 = no disability; 5 - 14 = mild disability; 15 - 24 = moderate disability; 25 - 34 = severe disability, above 34 = complete disability.

Countries

Belgium

Contacts

Primary ContactPanayota Kapessidou, MD,PhD
pkapessi@ulb.ac.be+32.2.535
Backup ContactMohamed Ali Bali, MD
mohamed_bali@stpierre-bru.be+ 32.2.535

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026